Uppsala Therapeutics AB
559027-4204ActiveDeveloping nanoparticle platforms for targeted drug delivery across the BBB.
Oversigt
- 0
- Medarbejdere
- 0 SEK
- Omsætning
- 2015
- Grundlagt
Nøglebeslutningstagere
Oommen Varghese
Co-Founder & Chief Scientific Officer (CSO)
Jöns Hilborn
Co-Founder
Victor Hartman
CEO
O. P. Oommen
Co-Founder
Beskrivelse
Uppsala Therapeutics is an innovative biopharmaceutical company specializing in advanced drug delivery systems. The core of their work involves developing proprietary nanoparticle-based therapies designed to carry small molecule and oligonucleotide drugs. Their technology originates from cutting-edg...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559027420401
Beslutningstagere
4 kontakter i FunnelfeedrOommen Varghese
Co-Founder & Chief Scientific Officer (CSO)
Jöns Hilborn
Co-Founder
Victor Hartman
CEO
O. P. Oommen
Co-Founder
Lignende virksomheder
20 lignende virksomheder i FunnelfeedrKey2Brain AB
10–19 medarbejdereDeveloping proprietary technology for next-generation brain targeting therapeutics.
Double Bond Pharmaceutical AB
5–9 medarbejdereDeveloping advanced drug delivery systems for targeted cancer and pneumonia treatment.
Ambusol AB (publ)
1–4 medarbejderePioneering patented therapy to eradicate residual glioblastoma cells post-surgery.
Strike Pharma AB
7 medarbejdereSwedish biotech developing targeted LNP delivery for in vivo CAR-T therapies.
Theralia AB
0 medarbejderePioneering biotech revolutionizing drug delivery via TOUCAN technology.
Udforsk mere
Spørgsmål om Uppsala Therapeutics AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo